Strategic Acquisition Paw Print Genetics is part of Neogen Corporation after a 2021 acquisition, signaling strong backing and potential for expanded distribution, co-marketing, and access to broader product lines in veterinary diagnostics.

Scale and Reach With 1001-5000 employees and a multi-brand history (Paw Print Genetics, GVS, AvianDx, CatScan), there is established capacity for large-volume testing partnerships, enterprise onboarding, and channel partnerships with breeders, clinics, and institutions.

Broad Test Portfolio Offering over 350 genetic tests across 350+ breeds creates opportunities to upsell premium breed-specific panels, recurring testing subscriptions, and bundled diagnostic services for breeders, show dogs, and working dogs.

Quality and Compliance Positioned as a laboratory-grade operation with high accuracy (99%) and rigorous safety/testing standards, enabling sales angles focused on reliability for veterinarians, breeders, and competitors seeking trusted genetic health solutions.

Growth Momentum Historical Inc. 5000 recognition and ongoing product launches (new tests, new brands) indicate rapid growth and opportunity for partner-led co-marketing, sponsored trials, and expansion into adjacent markets such as cats, birds, and other companion animals.